For how many days should Augmentin (amoxicillin‑clavulanate) be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Augmentin (Amoxicillin-Clavulanate) Treatment

For acute bacterial rhinosinusitis (ABRS), prescribe Augmentin for 5 to 10 days 1. This is the most common indication where duration matters clinically, and the guideline provides clear flexibility within this range.

Condition-Specific Duration Recommendations

Acute Bacterial Rhinosinusitis (ABRS)

  • Duration: 5-10 days 1
  • The 2015 American Academy of Otolaryngology guideline explicitly states this range for most adults with uncomplicated ABRS
  • Choose 5 days for: Mild disease, no recent antibiotic use, immunocompetent patients
  • Choose 10 days for: Moderate disease, recent antibiotic exposure (within 4-6 weeks), or risk factors for resistant pathogens 2

Acute Otitis Media (Pediatric)

  • Duration: 10 days 3
  • FDA labeling for Augmentin ES-600 specifically indicates 10-day treatment
  • Clinical trials demonstrating efficacy used this duration consistently
  • Administered as 90 mg/kg/day divided every 12 hours

Acute Exacerbations of Chronic Bronchitis

  • Duration: 5-7 days 4
  • High-dose formulation (2000/125 mg twice daily) for 5 days showed equivalent efficacy to standard dose (875/125 mg twice daily) for 7 days
  • Both regimens achieved >90% clinical success rates

Complicated Parapneumonic Effusions

  • Duration: 14 days minimum 5
  • After achieving clinical stability at 2 weeks, treatment can be safely discontinued
  • Extending to 3 weeks showed no additional benefit in a randomized trial

Protracted Bacterial Bronchitis (Pediatric)

  • Duration: 2-4 weeks 6
  • 2 weeks is adequate for initial clinical cure (70% success rate)
  • 4 weeks provides longer cough-free period (median 150 vs 36 days to next exacerbation)
  • Consider 4-week course for: Recurrent cases or children with frequent exacerbations

Key Clinical Pitfalls to Avoid

Don't underdose the amoxicillin component: For resistant pathogens (particularly penicillin-resistant S. pneumoniae), use high-dose formulations:

  • Adults: 2000 mg amoxicillin component twice daily or 875 mg three times daily
  • Children: 90 mg/kg/day of amoxicillin component 2, 3

Don't confuse formulations: Augmentin ES-600 (600 mg/42.9 mg per 5 mL) is NOT interchangeable with standard suspensions due to different clavulanate ratios 3. This matters for dosing accuracy.

Don't extend duration without reassessment: If symptoms worsen or fail to improve by day 7, reassess for complications or alternative diagnoses rather than simply continuing antibiotics 1.

Administration Considerations

  • Take with food to minimize gastrointestinal side effects and enhance clavulanate absorption 3
  • Refrigerate reconstituted suspension; stable for 10 days 3
  • Protocol-defined diarrhea occurs in approximately 11-13% of patients but rarely requires discontinuation 3

Evidence Quality Note

The sinusitis guideline 1 represents the highest-quality, most recent guidance for the most common indication. The 5-10 day range balances efficacy against antimicrobial stewardship concerns. Shorter courses (5 days) are increasingly supported for uncomplicated cases, while the traditional 10-day duration remains appropriate for more severe presentations or resistant pathogen risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.